Alexion Pharmaceuticals

Contact Us Legal Sitemap
  • About Us
  • Soliris & PNH
  • R & D
  • Investors
  • Careers
  • News

Sitemap

  • Home
  • Contact
  • Legal
    • Privacy Policy
    • Terms
  • Sitemap
    • About Us
      • Overview
      • Leadership
        • Management Team
        • Board of Directors
      • Mission
      • Ultra-Rare Diseases
      • Public Policy
      • Advocacy
      • Partnering
      • Global Capabilities
      • Milestones
      • Stories
        • Patrice
    • Soliris & PNH
      • About PNH
        • Hemolysis
        • Effects
        • Prevalence
        • Symptoms
        • Diagnosis
        • Treatment
      • About Soliris
        • Access
        • Development
        • Clinical Data
        • Publications
      • Prescribing Info
      • Important Safety Info
      • Additional Resources
      • References
      • Stories
        • Jules
        • Maria
        • Melissa
        • Paula
    • R & D
      • Pipeline
      • Complement Platform
        • Complement Biology
        • Complement Inhibition
      • Antibody Platform
      • Soliris in PNH
        • PNH Clinical Programs
        • PNH Diagnosis
        • PNH Registry
      • Soliris In Other Diseases
        • Hematology
        • Kidney Disorders
        • Neurology
        • New Formulations
        • Intellectual Property
      • Anti-CD200 Antibody
      • Clinical Trials
      • Publications
      • References
      • Stories
        • Stephen
    • Investors
      • Upcoming Presentations
      • Annual Reports to Shareholders
      • SEC Filings
      • Stock Information
        • Stock History
        • Investment Calculator
      • Shareholder Tools
    • Careers
      • Discover Alexion
        • Facts & Figures
        • Photo Gallery
        • FAQ
      • Meet Our Team
      • Why Choose Alexion
        • Culture
        • Corporate Responsibility
        • Professional Development
        • Awards & Recognition
      • Locations
      • Job Opportunities
      • Compensation & Benefits
      • Policies
    • News
      • Archives
        • 2008
        • 2007
        • 2006
      • Highlights
      • Media Kit
      • Inquiries


Please see full Prescribing Information and Important Safety Information for Soliris® (eculizumab).

About Us Soliris & PNH R&D Investors Careers News